...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: someone doesn’t believe in rumours…

Dumped over 41k shares @.16 - maybe an estate tidying up or something more sinister lol - great buy imo.

have a good weekend all 

 

Share
New Message
Please login to post a reply